Insurers should consider greater transparency regarding the calculation of out-of-network reimbursements and insureds' potential liability for excess charges.
In a case filed last year, an insured brought a class action against Health Care Service Corporation, the parent company to the administrator of the plaintiff's employer's ERISA group health plan. The class action alleges that the plan administrator breached its obligation to the plaintiff and others by systematically underpaying for out-of-network services (in part due to the Ingenix database), failing to disclose the basis for out-of-network reimbursement rates, and leaving the insureds personally responsible for a greater share of the costs for those services.
However, this shield has been subject to increasing attack. The recent healthcare legislation also may lead to an increase in insureds outside of the traditional confines of ERISA altogether. Several states recently have enacted bans or other limits on discretionary clauses, including California, Illinois, Michigan, New Jersey, and New York, and still others are considering such limits.
These bans have been subject to court challenges, which have mostly gone in favor of the states. Without discretionary clauses, administrators' decisions could be subject to a "fresh look" and complete re-review by courts, which may not bode well for insurers in the insured versus insurer context.
BALANCING INFORMATION NEEDS
As insureds become more proactive in healthcare decisions, it would not be surprising to see an increase in the use of out-of-network providers. With simultaneous limits on the ability of insurers/administrators to seek protection under ERISA, lawsuits may portend a disturbing trend for insurers and present a challenge regarding how best to inform insureds about the scope of out-of-network benefits, while protecting the proprietary nature of reimbursement rates.
Insurers should consider greater transparency in plan materials regarding the calculation of out-of-network reimbursements and insureds' potential liability for excess charges. Further, a thorough paper trail and upfront disclosures may be more valuable when faced with a court's re-review.
Christopher Williams is a partner with Calfee, Halter & Griswold LLP.
Laura McBride is an associate with Calfee, Halter & Griswold LLP.
Breaking Down Health Plans, HSAs, AI With Paul Fronstin of EBRI
November 19th 2024Featured in this latest episode of Tuning In to the C-Suite podcast is Paul Fronstin, director of health benefits research at EBRI, who shed light on the evolving landscape of health benefits with editors of Managed Healthcare Executive.
Listen
New PTSD Treatment Shows Promise with Brexpiprazole, Sertraline Combination
December 24th 2024Currently, the only medications approved by the FDA for PTSD are the selective serotonin reuptake inhibitors (SSRIs) sertraline and paroxetine. However, these medications don’t work for everyone.
Read More
In this latest episode of Tuning In to the C-Suite podcast, Briana Contreras, an editor with MHE had the pleasure of meeting Loren McCaghy, director of consulting, health and consumer engagement and product insight at Accenture, to discuss the organization's latest report on U.S. consumers switching healthcare providers and insurance payers.
Listen
How the Contact Center Can Be a Driver of VBC Success
December 23rd 2024Historically, healthcare organizations have considered the contact center to be a cost center, a communications platform for conveying information to patients and plan members. Today, however, AI-enabled contact centers can be drivers of value, especially in a value-based care environment.
Read More